---
$id: https://graph.org.ai/products/commodity/51271618
$type: Product
source: UNSPSC
code: "51271618"
title: "Ropivacaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ropivacaine

**UNSPSC Code**: 51271618
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant with the molecular formula C17H26N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7IO5LYA57N, chemically known as n-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide but generally known as ropivacaine, which bears US NIH Compound Identifier 71273. European Medicines Agency schedules Ropivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10382MIG. The term ROPIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). World Health Organization schedules ropivacaine in its Anatomical Therapeutic Chemical (ATC) Classification. ROPIVACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ropivacaine under HS 29333999 and SITC 51574. As of Q4 2014, ROPIVACAINE remains the US FDA Preferred Term for this commodity. Ropivacaine bears US NLM identifiers UMLS ID C0073571 and NCI Concept Code C61932. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)CCC.

